Aehr Test Systems, Inc. (AEHR)
NASDAQ: AEHR · Real-Time Price · USD
14.11
-0.48 (-3.29%)
At close: Jul 11, 2025, 4:00 PM
14.13
+0.02 (0.14%)
After-hours: Jul 11, 2025, 7:59 PM EDT
Aehr Test Systems Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Aehr Test Systems.
Price Target: n/a
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Aehr Test Systems.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 |
Buy | 1 | 1 | 1 | 0 |
Hold | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Craig-Hallum | Craig-Hallum | Strong Buy → Hold Downgrades $12 | Strong Buy → Hold | Downgrades | $12 | -14.95% | Mar 26, 2024 |
William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Mar 25, 2024 |
William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Oct 17, 2022 |
Financial Forecast
Revenue This Year
66.42M
from 58.97M
Increased by 12.64%
Revenue Next Year
89.29M
from 66.42M
Increased by 34.43%
EPS This Year
0.13
from -0.13
EPS Next Year
0.47
from 0.13
Increased by 268.00%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2026 | 2027 |
---|---|---|
High | 79.6M | 103.6M |
Avg | 66.4M | 89.3M |
Low | 54.6M | 73.3M |
Revenue Growth
Revenue Growth | 2026 | 2027 |
---|---|---|
High | 34.9% | 56.0% |
Avg | 12.6% | 34.4% |
Low | -7.4% | 10.4% |
EPS Forecast
EPS | 2026 | 2027 |
---|---|---|
High | 0.16 | 0.48 |
Avg | 0.13 | 0.47 |
Low | 0.10 | 0.45 |
EPS Growth
EPS Growth | 2026 | 2027 |
---|---|---|
High | - | 278.8% |
Avg | - | 268.0% |
Low | - | 253.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.